Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genome Diagnostics Laboratory, |
RCV002277788 | SCV002564817 | uncertain significance | Osteogenesis imperfecta | 2022-06-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003560918 | SCV004291727 | pathogenic | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ALPL protein function. ClinVar contains an entry for this variant (Variation ID: 1702003). This missense change has been observed in individual(s) with hypophosphatasia (PMID: 17395561; Invitae). This variant is present in population databases (rs752641050, gnomAD 0.004%). This sequence change replaces methionine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 226 of the ALPL protein (p.Met226Thr). |
Gene |
RCV003560918 | SCV005626470 | likely pathogenic | not provided | 2024-07-11 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 17395561) |